🔎 Trials Near Me

Utama › Pendarahan › California

Kajian klinikal Pendarahan di California

12 kajian untuk Pendarahan sedang mencari peserta di lokasi di California.

Bandar di California

Teks kajian rasmi (Bahasa Inggeris)

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

  • The Regents of the University of California||UC Davis Health, Rancho Cordova
  • UC Davis Health, Sacramento
  • UC Davis Ambulatory Care Clinic, Sacramento
  • dan 3 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Lelaki · Dikemas kini 2 Okt 2026 · NCT05568719

CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial

  • Zuckerberg San Francisco General Hospital and Trauma Center at University of California, San Francisco, San Francisco
Mengambil pesertaFasa 2
Umur 18 hingga 90 · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05958342

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  • Mission Cardiovascular Research Institute, Fremont
  • National Institute of California Heart and Vein Specialists, Huntington Beach
  • Profound Research LLC at San Diego Cardiovascular Associates, La Jolla
  • dan 5 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07626411

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

  • Valley Clinical Trials, Inc, Covina
  • North Coast Cardiology, Encinitas
  • Mission Cardiovascular Research Institute, Fremont
  • dan 7 lagi
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07175428

Onyx™ Liquid Embolic IDE Clinical Study

  • University of California, Irvine, Irvine
  • Stanford Medical Center, Palo Alto
Mengambil peserta
Umur 22 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06742801

A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Sep 2026 · NCT06722235

A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia

  • USC Norris Comprehensive Cancer Center - Keck Medicine of USC, Los Angeles
  • University of California San Diego Center for Bleeding and Clotting Disorders, San Diego
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06948318

Oxytocin Pharmacokinetics and Pharmacodynamics

  • Stanford University, Stanford
Mengambil pesertaFasa 2
Umur 18 hingga 50 · Wanita · Dikemas kini 21 Ogo 2026 · NCT05488457

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

  • Lucile Packard Children's Hospital, Palo Alto
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 0 hingga 20 · Semua jantina · Dikemas kini 21 Ogo 2026 · NCT04278404

A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery

  • Torrance Memorial, Torrance
Mengambil pesertaFasa 3
1 Month · Semua jantina · Dikemas kini 30 Jun 2026 · NCT06664775

Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  • University of Southern California, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
  • Stanford University, Stanford
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 26 Jun 2026 · NCT04045665

Tranexamic Acid for Second Trimester Dilation and Evacuation and Bleeding Outcomes

  • University of California San Diego, San Diego
  • Planned Parenthood of the Pacific Southwest, San Diego
Mengambil pesertaFasa 4Sukarelawan sihat dialu-alukan
Umur 18 ke atas · Wanita · Dikemas kini 15 Jun 2026 · NCT06820177

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.